Blueberry Therapeutics have unique nanopolymer drug delivery technology which opens up huge opportunities to rapidly develop new medicines and helps us find ways to treat dermatological disorders.
Latest News
Dermatology
Blueberry is committed to the development of innovative new therapies for the treatment of common dermatological disorders.
Nanomedicine
We use cutting-edge nano polymer drug delivery technology to exploit both small molecule and biologic approaches to developing treatments.
News
Anita Murray joins the Blueberry team as a Regulatory Affairs Director
Blueberry Therapeutics would like to extend a warm welcome to our newly appointed Regulatory Affairs Director, Anita Murray. Anita [...]
The rise of resistant Candida auris – A global issue
Fungal ‘superbug’ drug-resistant Candida auris has been identified by the Centres for Disease Control and Prevention (CDC) as a ‘serious threat to global health’ following a [...]
A Blueberry case study
In this video, CEO John Ridden and CSO David Cook talk about the early days of Blueberry Therapeutics, the short term and long term plans for the company, and the benefits of being based at Alderley Park, Cheshire.